✦ LIBER ✦

Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China

✍ Scribed by J. SHI; Y. ZHAO; J. WU; J. SUN; L. WANG; R. YANG

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety evaluation of sucros

✍ J.-H. YOUNG; H.-C. LIU; E.-J. HSUEH; M.-L. HUANG; C.-T. PENG; R.-L. CHEN; M. MAA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

Cumulative analysis of inhibitor formati

✍ N. BAJWA; M. M. ENRIQUEZ; E. GORINA; G. LEMM 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Stability, efficacy, and safety of conti

✍ U. MARTINOWITZ; J. LUBOSHITZ; D. BASHARI; B. RAVID; E. GORINA; L. REGAN; H. STAS 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Efficacy and inhibitor development in pr

✍ Alessandro Gringeri; Annarita Tagliaferri; Giuseppe Tagariello; Massimo Morfini; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Clinical efficacy, safety and pharmacoki

✍ D. M. Wolf; R. Rokicka-Milewska; S. Lopaciuk; A. B. Skotnicki; A. Klukowska; P. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Plasma and albumin-free recombinant fact

✍ V. S. BLANCHETTE; A. D. SHAPIRO; R. J. LIESNER; F. HERNÁNDEZ NAVARRO; I. WARRIER 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB